Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis (Q46286038)

From Wikidata
Jump to navigation Jump to search
scientific article published on 2 June 2013
edit
Language Label Description Also known as
English
Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis
scientific article published on 2 June 2013

    Statements

    Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis (English)
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit